SCHEMBL6911735

SCHEMBL6911735

COC[C@@H]1CN(c2ccccc2)CCN1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB1 P08588 9/20 0.60
HTR3E A5X5Y0 1/20 0.43
HTR3B O95264 1/20 0.43
HTR3A P46098 1/20 0.43
HTR3D Q70Z44 1/20 0.43
HTR3C Q8WXA8 1/20 0.43
SIGMAR1 Q99720 1/20 0.43
PRKCQ Q04759 1/20 0.43
KHK P50053 2/20 0.41
HTR1A P08908 1/20 0.41
HTR1D P28221 1/20 0.41
HTR2A P28223 1/20 0.41
HRH1 P35367 1/20 0.41
ADRA1B P35368 1/20 0.41
KCNH2 Q12809 1/20 0.41
REN P00797 1/20 0.41
LTA4H P09960 1/20 0.40
DRD2 P14416 1/20 0.39
DRD4 P21917 1/20 0.39
ALDH1A1 P00352 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6911746 1.00 ADRB1 (0.60) ADRB1HTR3EHTR3BHTR3AHTR3D
SCHEMBL22542075 0.87 ADRB1 (0.47) ADRB1HTR3EHTR3BHTR3AHTR3D
SCHEMBL24478521 0.84 ADRB1 (0.46) ADRB1HTR3EHTR3BHTR3AHTR3D
SCHEMBL24451886 0.83 ADRB1 (0.45) ADRB1HTR3EHTR3BHTR3AHTR3D
SCHEMBL24478560 0.83 ADRB1 (0.45) ADRB1HTR3EHTR3BHTR3AHTR3D
SCHEMBL24478165 0.83 ADRB1 (0.45) ADRB1HTR3EHTR3BHTR3AHTR3D
SCHEMBL27519529 0.80 ADRB1 (0.57) ADRB1HTR3EHTR3BHTR3AHTR3D
SCHEMBL6907013 0.80 ADRB1 (0.60) ADRB1HTR3EHTR3BHTR3AHTR3D
SCHEMBL6907009 0.80 ADRB1 (0.60) ADRB1HTR3EHTR3BHTR3AHTR3D
Hydrochloric Acid SCHEMBL31087090 0.78 PRKCQ (0.52) ADRB1PRKCQRENDRD2DRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6825200-B1 TREATING, PROLONGING, OR EXTENDING THE ONSET OF ORGAN REJECTION IN A HUMAN DURING OR AFTER ORGAN TRANSPLANTATION IN A HUMAN FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-11-30 US disclosed
EP-1226159-A1 SUBSTITUTED DIPEPTIDES HAVING NOS INHIBITING ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-07-31 EP disclosed
WO-2001032690-A1 SUBSTITUTED DIPEPTIDES HAVING NOS INHIBITING ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-05-10 WO disclosed